ARHGEF9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.201600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.796400E-01
Normal-vs-Stage2
5.280800E-01
Normal-vs-Stage3
5.332000E-01
Normal-vs-Stage4
9.080400E-01
Stage1-vs-Stage2
1.047600E-01
Stage1-vs-Stage3
2.437000E-01
Stage1-vs-Stage4
8.018000E-01
Stage2-vs-Stage3
6.821000E-01
Stage2-vs-Stage4
3.449600E-01
Stage3-vs-Stage4
4.767000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.559400E-01
Normal-vs-AfricanAmerican
5.145200E-01
Normal-vs-Asian
4.193200E-01
Caucasian-vs-AfricanAmerican
5.844800E-01
Caucasian-vs-Asian
4.028600E-01
AfricanAmerican-vs-Asian
9.267600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.188200E-01
Normal-vs-Female
8.366600E-01
Male-vs-Female
8.361400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.932600E-01
Normal-vs-Age(41-60Yrs)
9.421800E-01
Normal-vs-Age(61-80Yrs)
7.041800E-01
Normal-vs-Age(81-100Yrs)
3.280400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.114800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.656800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.925200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.236240E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.605900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.273200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.128600E-01
Normal-vs-Daily Drinker
5.391600E-01
Normal-vs-Weekly Drinker
8.259400E-01
Normal-vs-Occasional Drinker
7.802800E-01
Normal-vs-Social Drinker
7.892800E-01
Non Drinker-vs-Daily Drinker
5.936800E-01
Non Drinker-vs-Weekly Drinker
1.284030E-01
Non Drinker-vs-Occasional Drinker
6.535700E-02
Non Drinker-vs-Social Drinker
1.033230E-01
Daily Drinker-vs-Weekly Drinker
4.643000E-01
Daily Drinker-vs-Occasional Drinker
1.482230E-01
Daily Drinker-vs-Social Drinker
1.938230E-01
Weekly Drinker-vs-Occasional Drinker
3.804000E-01
Weekly Drinker-vs-Social Drinker
4.255800E-01
Occasional Drinker-vs-Social Drinker
9.972400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.723400E-01
Normal-vs-Grade 2
9.393700E-02
Normal-vs-Grade 3
6.512300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.191200E-01
Grade 1-vs-Grade 3
1.077190E-01
Grade 1-vs-Grade 4
2.723400E-01
Grade 2-vs-Grade 3
2.864400E-01
Grade 2-vs-Grade 4
9.393700E-02
Grade 3-vs-Grade 4
6.512300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.117200E-01
Normal-vs-NonDiabetic
8.345000E-01
Diabetic-vs-NonDiabetic
6.093000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.282600E-01
Normal-vs-NoPancreatitis
7.972400E-01
Pancreatitis-vs-NoPancreatitis
9.309800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.627000E-01
Normal-vs-N1
5.350800E-01
N0-vs-N1
2.725900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.807800E-01
Normal-vs-TP53-NonMutant
7.848000E-01
TP53-Mutant-vs-TP53-NonMutant
1.720470E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
